Concepedia

Hatice Satilmis

HS

Statistics

Publications

6

Citations

124

H-Index

6

Active since

2022

Affiliations

Ghent University Hospital(Current)

Vrije Universiteit Brussel

Universitair Ziekenhuis Brussel

VIB-UGent Center for Inflammation Research

Active Biotech (Sweden)

Hatice Satilmis is an author at Ghent University Hospital specializing in pharmacology, oncology, and medicine.

Publications per year

2022–2024

6

Publications

6

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 31 citations · Full text

, , +15

Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis

Arne Van der Vreken, Inge Oudaert, Gamze Ates et al. · The Journal of Pathology · 2023 · 29 citations · Full text

, , +15

Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma

Rong Fan, Hatice Satilmis, Niels Vandewalle et al. · Journal for ImmunoTherapy of Cancer · 2023 · 22 citations · Full text

, , +16

Targeting the β <sub>2</sub> ‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism

Hatice Satilmis, Emma Verheye, Philip Vlummens et al. · The Journal of Pathology · 2022 · 16 citations · Full text

, , +17

Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia

Rong Fan, Hatice Satilmis, Niels Vandewalle et al. · Blood Cancer Journal · 2023 · 15 citations · Full text

, , +17

1–5 of 6